Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1982 Sep;79(18):5513–5517. doi: 10.1073/pnas.79.18.5513

Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: Exceptional activity of ellagic acid

Alexander W Wood *, Mou-Tuan Huang *, Richard L Chang *, Harold L Newmark †,‡, Roland E Lehr §, Haruhiko Yagi , Jane M Sayer , Donald M Jerina , Allan H Conney *
PMCID: PMC346934  PMID: 6752950

Abstract

Ferulic, caffeic, chlorogenic, and ellagic acids, four naturally occurring plant phenols, inhibit the mutagenicity and cytotoxicity of (±)-7β,8α-dihydroxy-9α, 10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (B[a]P 7,8-diol-9,10-epoxide-2), the only known ultimate carcinogenic metabolite of benzo[a]pyrene. The mutagenicity of 0.05 nmol of B[a]P 7,8-diol-9,10-epoxide-2 in strain TA100 of Salmonella typhimurium is inhibited 50% by incubation of the bacteria and the diol epoxide with 150 nmol of ferulic acid, 75 nmol of caffeic acid, 50 nmol of chlorogenic acid or, most strikingly, 1 nmol of ellagic acid in the 0.5-ml incubation mixture. A 3-nmol dose of ellagic acid inhibits mutation induction by 90%. Ellagic acid is also a potent antagonist of B[a]P 7,8-diol-9,10-epoxide-2 in Chinese hamster V79 cells. Mutations to 8-azaguanine resistance induced by 0.2 μM diol epoxide are reduced by 50% when tissue culture media also contains 2 μM ellagic acid. Similar to results obtained with the bacteria, ferulic, caffeic, and chlorogenic acids are approximately two orders of magnitude less active than ellagic acid in the mammalian cell assay. The antimutagenic effects of the plant phenols result from their direct interaction with B[a]P 7,8-diol-9,10-epoxide-2, because a concentration-dependent increase in the rate of diol epoxide disappearance in cell-free solutions of 1:9 dioxane/water, pH 7.0, is observed with all four phenols. In parallel with the mutagenicity studies, ellagic acid is 80-300 times more effective than the other phenols in accelerating the disappearance of B[a]P 7,8-diol-9,10-epoxide-2. Ellagic acid at 10 μM increases the disappearance of B[a]P 7,8-diol-9,10-epoxide-2 by approximately 20-fold relative to the spontaneous and hydronium ion-catalyzed hydrolysis of the diol epoxide at pH 7.0. Ellagic acid is a highly potent inhibitor of the mutagenic activity of bay-region diol epoxides of benzo[a]pyrene, dibenzo[a,h]pyrene, and dibenzo[a,i]pyrene, but higher concentrations of ellagic acid are needed to inhibit the mutagenic activity of the chemically less reactive bay-region diol epoxides of benz[a]anthracene, chrysene, and benzo[c]phenanthrene. These studies demonstrate that ellagic acid is a potent antagonist of the adverse biological effects of the ultimate carcinogenic metabolites of several polycyclic aromatic hydrocarbons and suggest that this naturally occurring plant phenol, normally ingested by humans, may inhibit the carcinogenicity of polycyclic aromatic hydrocarbons.

Keywords: ultimate carcinogen, Ames' Salmonella typhimurium, Chinese hamster V79 cells, kinetics of epoxide disappearance

Full text

PDF
5513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOTTI R. E., RATNOFF O. D. STUDIES ON THE PATHOGENESIS OF THROMBOSIS: AN EXPERIMENTAL "HYPERCOAGULABLE" STATE INDUCED BY THE INTRAVENOUS INJECTION OF ELLAGIC ACID. J Lab Clin Med. 1964 Sep;64:385–398. [PubMed] [Google Scholar]
  2. Bhargava U. C., Westfall B. A., Siehr D. J. Preliminary pharmacology of ellagic acid from Juglans nigra (black walnut). J Pharm Sci. 1968 Oct;57(10):1728–1732. doi: 10.1002/jps.2600571021. [DOI] [PubMed] [Google Scholar]
  3. Bock P. E., Srinivasan K. R., Shore J. D. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species. Biochemistry. 1981 Dec 8;20(25):7258–7266. doi: 10.1021/bi00528a032. [DOI] [PubMed] [Google Scholar]
  4. Dansette P., Jerina D. M. A facile synthesis of arene oxides at the K regions of polycylic hydrocarbons. J Am Chem Soc. 1974 Feb 20;96(4):1224–1225. doi: 10.1021/ja00811a046. [DOI] [PubMed] [Google Scholar]
  5. GRINSTEAD R. R. METAL-CATALYZED OXIDATION OF 3,5-DI-T-BUTYL PYROCATECHOL, AND ITS SIGNIFICANCE IN THE MECHANISM OF PYROCATECHASE ACTION. Biochemistry. 1964 Sep;3:1308–1314. doi: 10.1021/bi00897a021. [DOI] [PubMed] [Google Scholar]
  6. Girolami A., Agostino D., Cliffton E. E. The effect of ellagic acid on coagulation in vivo. Blood. 1966 Jan;27(1):93–102. [PubMed] [Google Scholar]
  7. Girolami A., Cliffton E. E. Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid. Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):165–175. [PubMed] [Google Scholar]
  8. Kapitulnik J., Wislocki P. G., Levin W., Yagi H., Jerina D. M., Conney A. H. Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice. Cancer Res. 1978 Feb;38(2):354–358. [PubMed] [Google Scholar]
  9. Stich H. F., Rosin M. P., Wu C. H., Powrie W. D. A comparative genotoxicity study of chlorogenic acid (3-0-caffeoylquinic acid). Mutat Res. 1981 Nov;90(3):201–212. doi: 10.1016/0165-1218(81)90001-x. [DOI] [PubMed] [Google Scholar]
  10. Stich H. F., Rosin M. P., Wu C. H., Powrie W. D. The action of transition metals on the genotoxicity of simple phenols, phenolic acids and cinnamic acids. Cancer Lett. 1981 Dec;14(3):251–260. doi: 10.1016/0304-3835(81)90151-8. [DOI] [PubMed] [Google Scholar]
  11. Tyson C. A., Martell A. E. Kinetics and mechanism of the metal chelate catalyzed oxidation of pyrocatechols. J Am Chem Soc. 1972 Feb 9;94(3):939–945. doi: 10.1021/ja00758a036. [DOI] [PubMed] [Google Scholar]
  12. Wattenberg L. W., Coccia J. B., Lam L. K. Inhibitory effects of phenolic compounds on benzo(a)pyrene-induced neoplasia. Cancer Res. 1980 Aug;40(8 Pt 1):2820–2823. [PubMed] [Google Scholar]
  13. Wislocki P. G., Kapitulnik J., Levin W., Conney A. H. Tumorigenicity of benzo[alpha]pyrene 4,5-,7,8-,9,10- and 11,12-oxides in newborn mice. Cancer Lett. 1978 Oct;5(4):191–197. doi: 10.1016/s0304-3835(78)80038-x. [DOI] [PubMed] [Google Scholar]
  14. Wood A. W., Chang R. L., Levin W., Lehr R. E., Schaefer-Ridder M., Karle J. M., Jerina D. M., Conney A. H. Mutagenicity and cytotoxicity of benz[alpha]anthracene diol epoxides and tetrahydro-epoxides: exceptional activity of the bay region 1,2-epoxides. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2746–2750. doi: 10.1073/pnas.74.7.2746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wood A. W., Chang R. L., Levin W., Ryan D. E., Thomas P. E., Lehr R. E., Kumar S., Sardella D. J., Boger E., Yagi H. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene. Cancer Res. 1981 Jul;41(7):2589–2597. [PubMed] [Google Scholar]
  16. Wood A. W., Sayer J. M., Newmark H. L., Yagi H., Michaud D. P., Jerina D. M., Conney A. H. Mechanism of the inhibition of mutagenicity of a benzo[a]pyrene 7,8-diol 9,10-epoxide by riboflavin 5'-phosphate. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5122–5126. doi: 10.1073/pnas.79.17.5122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yagi H., Hernandez O., Jerina D. M. Letter: Synthesis of (+/-)-7 beta,8alpha-dihydroxy-9 beta,10beta-epoxy-7,8,-9,10-tetrahydrobenzo(a)pyrene, a potential metabolite of the carcinogen benzo(a)pyrene with stereochemistry related to the antileukemic triptolides. J Am Chem Soc. 1975 Nov 12;97(23):6881–6883. doi: 10.1021/ja00856a057. [DOI] [PubMed] [Google Scholar]
  18. Yagi H., Thakker D. R., Hernandez O., Koreeda M., Jerina D. M. Synthesis and reactions of the highly mutagenic 7,8-diol 9,10-epoxides of the carcinogen benzo[a]pyrene. J Am Chem Soc. 1977 Mar 2;99(5):1604–1611. doi: 10.1021/ja00447a053. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES